Sermorelin
10mg
Sermorelin 10mg
New Releases

Sermorelin

GHRH Analog

$45.00
Third-Party Lab Tested
COA With Every Order
Fast U.S. Shipping
Text Email

What It Is

A synthetic 29-amino-acid peptide corresponding to the biologically active fragment (1–29) of human growth hormone-releasing hormone (GHRH). Studied as a tool for investigating pituitary-driven, pulsatile growth hormone release in research models.

How It Works

1
Sermorelin reaches the anterior pituitary
2
Binds GHRH receptors on somatotroph cells
3
Pulsatile growth hormone release is initiated
4
Downstream IGF-1 signaling is studied

What Researchers Study It For

Pituitary GH-axis function studies
Pulsatile vs. tonic hormone-release models
Aging-related GH-decline investigations
IGF-1 signaling pathway research

Common Research Protocols

In published research, Sermorelin is reconstituted with bacteriostatic water and administered subcutaneously, with literature protocols emphasizing low-volume, evening-timed dosing to align with natural GH pulses.

Community Interest Areas

The endocrine-research community has long studied Sermorelin because it preserves the pulsatile architecture of native GH release rather than producing a sustained elevation. This makes it a useful comparator to direct GH administration in models of somatopause, body-composition changes, and GH-axis feedback dynamics.

GHRH(1-29) Active fragment of human growth hormone-releasing hormone
Pulsatile Preserves native pulsatile GH release in research models

For research purposes only. Not intended for consumption, clinical application, or diagnostic use.